LCTX
Price
$1.70
Change
+$0.03 (+1.80%)
Updated
Jan 14 closing price
Capitalization
391.56M
49 days until earnings call
Intraday BUY SELL Signals
RVPH
Price
$0.35
Change
-$0.00 (-0.00%)
Updated
Jan 14 closing price
Capitalization
40.9M
67 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LCTX vs RVPH

Header iconLCTX vs RVPH Comparison
Open Charts LCTX vs RVPHBanner chart's image
Lineage Cell Therapeutics
Price$1.70
Change+$0.03 (+1.80%)
Volume$791.31K
Capitalization391.56M
Reviva Pharmaceuticals Holdings
Price$0.35
Change-$0.00 (-0.00%)
Volume$2.93M
Capitalization40.9M
LCTX vs RVPH Comparison Chart in %
LCTX
Daily Signal:
Gain/Loss:
RVPH
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LCTX vs. RVPH commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a Hold and RVPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (LCTX: $1.70 vs. RVPH: $0.35)
Brand notoriety: LCTX and RVPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 49% vs. RVPH: 48%
Market capitalization -- LCTX: $391.56M vs. RVPH: $40.9M
LCTX [@Biotechnology] is valued at $391.56M. RVPH’s [@Biotechnology] market capitalization is $40.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileRVPH’s FA Score has 1 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • RVPH’s FA Score: 1 green, 4 red.
According to our system of comparison, LCTX is a better buy in the long-term than RVPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 4 TA indicator(s) are bullish while RVPH’s TA Score has 6 bullish TA indicator(s).

  • LCTX’s TA Score: 4 bullish, 4 bearish.
  • RVPH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RVPH is a better buy in the short-term than LCTX.

Price Growth

LCTX (@Biotechnology) experienced а -7.10% price change this week, while RVPH (@Biotechnology) price change was +1.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

LCTX is expected to report earnings on Mar 05, 2026.

RVPH is expected to report earnings on Mar 23, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($392M) has a higher market cap than RVPH($40.9M). RVPH YTD gains are higher at: 25.448 vs. LCTX (1.796). LCTX has higher annual earnings (EBITDA): -19.68M vs. RVPH (-22.71M). LCTX has more cash in the bank: 40.5M vs. RVPH (13.2M). RVPH has less debt than LCTX: RVPH (113K) vs LCTX (2.62M). LCTX has higher revenues than RVPH: LCTX (10.8M) vs RVPH (0).
LCTXRVPHLCTX / RVPH
Capitalization392M40.9M958%
EBITDA-19.68M-22.71M87%
Gain YTD1.79625.4487%
P/E RatioN/AN/A-
Revenue10.8M0-
Total Cash40.5M13.2M307%
Total Debt2.62M113K2,319%
FUNDAMENTALS RATINGS
LCTX vs RVPH: Fundamental Ratings
LCTX
RVPH
OUTLOOK RATING
1..100
602
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
3894
P/E GROWTH RATING
1..100
6212
SEASONALITY SCORE
1..100
5012

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (65) in the null industry is in the same range as RVPH (92). This means that LCTX’s stock grew similarly to RVPH’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as RVPH (100). This means that LCTX’s stock grew similarly to RVPH’s over the last 12 months.

LCTX's SMR Rating (99) in the null industry is in the same range as RVPH (100). This means that LCTX’s stock grew similarly to RVPH’s over the last 12 months.

LCTX's Price Growth Rating (38) in the null industry is somewhat better than the same rating for RVPH (94). This means that LCTX’s stock grew somewhat faster than RVPH’s over the last 12 months.

RVPH's P/E Growth Rating (12) in the null industry is somewhat better than the same rating for LCTX (62). This means that RVPH’s stock grew somewhat faster than LCTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXRVPH
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 9 days ago
77%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
LCTX
Daily Signal:
Gain/Loss:
RVPH
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVS146.164.55
+3.21%
Novartis AG
ICL5.510.10
+1.85%
ICL Group Ltd
ARLO13.930.11
+0.80%
Arlo Technologies
RADX5.200.03
+0.58%
Radiopharm Theranostics Limited
GUTS2.01N/A
N/A
Fractyl Health

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+1.80%
MDGL - LCTX
43%
Loosely correlated
+2.29%
ABCL - LCTX
39%
Loosely correlated
+0.47%
CRSP - LCTX
37%
Loosely correlated
+1.26%
RXRX - LCTX
36%
Loosely correlated
+3.41%
VIR - LCTX
36%
Loosely correlated
+8.08%
More

RVPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVPH has been loosely correlated with ALT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RVPH jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
-1.41%
ALT - RVPH
50%
Loosely correlated
+4.24%
INM - RVPH
29%
Poorly correlated
-1.74%
LCTX - RVPH
29%
Poorly correlated
+1.80%
ABOS - RVPH
28%
Poorly correlated
+3.47%
INDP - RVPH
28%
Poorly correlated
+1.31%
More